List of AdipoGen Life Sciences’ SARS-CoV-2 recombinant antibodies
New SARS-CoV-2 Recombinant Antibodies
SURAMIN – A Multifunctional Small Molecule with over 100 Years of History
Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite and autism.
Resiniferatoxin (RTX) – Potent TRPV1 Agonist for Pain Relief
The plant Euphorbia resinifera contains the most potent irritant known so far. It was isolated and identified as resiniferatoxin (RTX).
Manumycin A – Exosome Biogenesis Inhibitor
Manumycin A is an inhibitor of exosome biogenesis & secretion. Targeting exosome biogenesis could exert RAS signalling inhibitors’ anticancer effects.
Nano Vaccines Induce T Cell Immunity and Control of Tumour Growth
Using nanoparticle technology in making vaccines for infectious diseases/cancer is advancing & enhances the immunogenicity of some vaccine candidates.
LEADGENE® Indoxyl Sulfate ELISA Kit: Rapid Detection and Surveillance of Chronic Kidney Disease
LEADGENE® Indoxyl Sulfate ELISA Kit is the first CE-registered antibody-based assay tool for chronic kidney disease (CKD) on the global market.
Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics – Press release
Leadgene Biomedical has announced the launch of LEADSPHERE™ Lyophilization Technology to aid in the dispense, storage, and transport of their reagents
Popular Targets for Bispecific Antibody Drugs
Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.
Is your drug candidate able to reverse the T Cell Exhaustion-like state in MBL’s in vitro functional screening assay?
The process of T cell exhaustion & how it can be harnessed for immuno-oncology drug discovery and for immune checkpoint screening of drug candidates.
Research Grade Biosimilar Antibodies from ProSci
Therapeutic antibodies dominate pipelines and top selling drugs at major pharmaceutical companies. They have proven to be valuable tools in the fight against diseases from cancer and autoimmune disorders to infectious and neurodegenerative diseases. Beyond therapeutics, monoclonal antibodies shown to